CoChat
Sign Up
Cited by 3Liver physiology and pathologyLiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record.

PS-091-Targeted disruption of TGF-B activation by an AVB1 integrin inhibitor significantly reduces liver fibrosis in CCl4 mice and Human NASH liver slices

schaub, johanna, Decaris, Martin, Reilly, Maureen, Lee, Gail, Martin, Shamra, Rao, Vickram, Chen, Chun, Rexhepaj, Meghi, Kotak, Perna, Hooi, Lisa, Leftheris, Katarina, Cha, Jake, Lepist, Irene, Andre, Patrick, Turner, Scott·2019·Journal of Hepatology
DOI 10.1016/s0618-8278(19)30103-3
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/s0618-8278(19)30103-3

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GARP, in cooperation with integrin αvβ8, is required for TGF-β1 activation at the surface of Treg cells.

    “Since GARP, in cooperation with integrin αvβ8, is required for TGF-β1 activation at the surface of Treg cells82,320”

    From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [320]

Citations

Cited by

Sorted by citations

Related

Metadata

Authors
schaub, J., Decaris, M., Reilly, M., Lee, G., Martin, S., Rao, V., Chen, C., Rexhepaj, M., Kotak, P., Hooi, L., Leftheris, K., Cha, J., Lepist, I., Andre, P., & Turner, S.
ORCID
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2019-04
Volume
70
Issue
1
Pages
e57-e58
ISSN
0168-8278 (ISSN-L)
DOI
10.1016/s0618-8278(19)30103-3
OpenAlex
W2937058428
Cited by
3
References
0
Citations by year
2023: 1 · 2020: 2
FWCI
0.32
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
Journal of Hepatology (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
TGF-beta activation, integrin inhibitors, liver fibrosis, nonalcoholic steatohepatitis, carbon tetrachloride-induced liver injury, human liver slices, antifibrotic therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review